GenDx Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 102

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 3

GenDx General Information

Description

Provider of molecular diagnostics tools intended for solid organ and stem cell transplantation. The company develops and offers a comprehensive line of reagents and services, analysis software and education for human leukocyte antigen (HLA) typing, thereby enabling healthcare providers and organizations to get crucial information for patient-tailored treatments.

Contact Information

Website
www.gendx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Corporate Office
  • Yalelaan 48
  • 3584 CM Utrecht
  • Netherlands
+31 030
Primary Industry
Medical Supplies
Other Industries
Other Healthcare Technology Systems
Parent Company
Eurobio Scientific
Vertical(s)
TMT, HealthTech
Corporate Office
  • Yalelaan 48
  • 3584 CM Utrecht
  • Netherlands
+31 030

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenDx‘s full profile, request access.

Request a free trial

GenDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of molecular diagnostics tools intended for solid organ and stem cell transplantation. The company develops and
Medical Supplies
Utrecht, Netherlands
102 As of 2025

Mechelen, Belgium
 

Eden Prairie, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenDx Competitors (2)

One of GenDx’s 2 competitors is Biocartis, a Formerly VC-backed company based in Mechelen, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocartis Formerly VC-backed Mechelen, Belgium
Surmodics Corporation Eden Prairie, MN
You’re viewing 2 of 2 competitors. Get the full list »

GenDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenDx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenDx‘s full profile, request access.

Request a free trial

GenDx Investments & Acquisitions (3)

GenDx’s most recent deal was a Corporate with Scope Biosciences for . The deal was made on 29-Oct-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Scope Biosciences 29-Oct-2021 Corporate Biotechnology
Kimerdx 01-Jan-2018 Merger/Acquisition Diagnostic Equipment
Kimerdx 31-Oct-2013 Joint Venture Diagnostic Equipment
To view GenDx’s complete investments and acquisitions history, request access »

GenDx FAQs

  • When was GenDx founded?

    GenDx was founded in 2005.

  • Where is GenDx headquartered?

    GenDx is headquartered in Utrecht, Netherlands.

  • What is the size of GenDx?

    GenDx has 102 total employees.

  • What industry is GenDx in?

    GenDx’s primary industry is Medical Supplies.

  • Is GenDx a private or public company?

    GenDx is a Private company.

  • What is the current valuation of GenDx?

    The current valuation of GenDx is .

  • What is GenDx’s current revenue?

    The current revenue for GenDx is .

  • Who are GenDx’s investors?

    Ampersand (Massachusetts) and Utrecht Holdings have invested in GenDx.

  • Who are GenDx’s competitors?

    Biocartis and Surmodics are competitors of GenDx.

  • When was GenDx acquired?

    GenDx was acquired on 17-Aug-2022.

  • Who acquired GenDx?

    GenDx was acquired by Eurobio Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »